According to Victor Ionascu, rather than replacing testing roles, AI can enhance them by predicting defects, automating test maintenance, and refining risk-based testing.

The US Food and Drug Administration (FDA) has approved an improved stool collection kit of Geneoscopy’s RNA-based colorectal ...

Previous guidance recommended risk-based testing in the third trimester for those living in communities with high syphilis rates and for those at risk of acquiring the infection during pregnancy.